EF-HB activators are a class of chemical compounds that specifically target and modulate the activity of the EF-Hand Binding (EF-HB) domain-containing proteins. These proteins are characterized by the presence of EF-hand motifs, which are helix-loop-helix structural domains capable of binding calcium ions. This binding is crucial for the regulation of various cellular processes, including signal transduction, muscle contraction, and the maintenance of cellular structure. The EF-HB activators interact with these domains to modulate their activity, which in turn can influence calcium signaling pathways within cells. Calcium ions play a pivotal role as secondary messengers in cellular signaling, and their regulated release and uptake are essential for the proper functioning of numerous cellular processes. By activating EF-HB domain-containing proteins, these compounds can affect the dynamics of calcium signaling, potentially altering the way cells respond to various stimuli and maintain calcium homeostasis.
The mechanism of action of EF-HB activators involves a complex interplay between the compound and the EF-hand motifs of the target proteins. These activators may bind to specific sites on the EF-HB domain, inducing conformational changes that either enhance the domain's ability to bind calcium or facilitate its interaction with other proteins involved in calcium signaling pathways. This modulation of protein activity can have cascading effects on cellular functions, as calcium signaling is integral to many physiological processes. The study of EF-HB activators provides valuable insights into the intricate mechanisms of cellular signaling and the role of calcium as a key regulatory ion. Through detailed biochemical and biophysical analyses, researchers aim to elucidate the precise interactions between these activators and their target domains, contributing to a deeper understanding of cellular regulation and the complex network of signaling pathways that govern cellular behavior.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcimycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting the expression of calcium-regulated genes like CFAP21. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $325.00 $632.00 $1428.00 $2450.00 $400.00 | 32 | |
Calcitriol, the active form of vitamin D, regulates gene expression through the vitamin D receptor and could affect calcium-binding protein genes such as CFAP21. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine blocks calcium channels, altering intracellular calcium and potentially influencing expression of calcium-sensitive genes like CFAP21. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium that could modulate CFAP21 expression. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil inhibits L-type calcium channels, which could perturb calcium signaling and affect genes associated with calcium binding, potentially including CFAP21. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB modulates calcium channels and signaling, possibly impacting the regulation of calcium-dependent genes like CFAP21. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $173.00 $612.00 | 3 | |
Cyclopiazonic acid is an inhibitor of SERCA, leading to increased cytosolic calcium levels, which may influence CFAP21 gene expression. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Bay K 8644 activates L-type calcium channels, potentially affecting calcium signaling and the expression of calcium-regulated genes such as CFAP21. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
SKF-96365 inhibits receptor-mediated calcium entry, potentially altering the expression of genes that respond to calcium fluctuations, including CFAP21. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
Nimodipine is a calcium channel blocker that could modify calcium signaling and potentially impact the expression of calcium-sensitive genes like CFAP21. |